touchPODCAST

touchMDT for touchONCOLOLOGY Listen to key experts from a multidisciplinary team explore the use of biomarkers in thyroid cancer care and how personalized medicine influences patient outcomes The multidisciplinary team  Pathologist: Dr Peter Sadow, USA Endocrinologist: Dr Antonio Matrone, Italy Oncologist: Dr Lori Wirth, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestr...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team (MDT) discuss the epidemiology of thyroid cancer, available treatment options, and the role of the MDT in patient care The multidisciplinary team Oncologist: Dr Lori Wirth, USA Endocrinologist: Dr Antonio Matrone, Italy Nurse specialist: Ms Tara Hurley, UK Pathologist: Dr Peter Sadow, USA This touchPODCAST is for HCPs o...

touchEXPERT OPINIONS for touchNEUROLOGY Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice. The experts Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA Prof. Helene A Emsel...

touchEXPERT OPINIONS for touchRESPIRATORY Listen to leading sleep medicine experts discuss strategies for the optimal management of excessive daytime sleepiness (EDS) associated with obstructive sleep apnea (OSA) or narcolepsy, and share insights and potential implications for clinical practice. The experts Dr Annamaria Iakovou – Northwell Health, Lake Success, New York, NY, USA Prof. Helene A Ems...

touchMDT for touchONCOLOGY Listen to a multidisciplinary tumour board consider the potential of systemic therapy in hepatocellular carcinoma during the current immunotherapy era. The multidisciplinary team Medical oncologist: Prof. Ahmed Kaseb, USA Radiation oncologist: Prof. Jinsil Seong, Korea Hepatologist: Prof. Peter Galle, Germany Surgical oncologist: Dr Michael Choti, USA This touchPODCAST i...

touchMDT for touchONCOLOGY Listen to a multidisciplinary tumour board discuss how recent developments are enabling the management of patients with hepatocellular carcinoma to become increasingly individualized. The multidisciplinary team Medical oncologist: Prof. Ahmed Kaseb, USA Radiation oncologist: Prof. Jinsil Seong, Korea Hepatologist: Prof. Peter Galle, Germany Surgical oncologist: Dr Michae...

touchMDT for touchONCOLOGY Listen to a multidisciplinary tumour board share their perspectives on a best practice multidisciplinary approach to patient care in the management of hepatocellular carcinoma. The multidisciplinary team Medical oncologist: Prof. Ahmed Kaseb, USA Radiation oncologist: Prof. Jinsil Seong, Korea Hepatologist: Prof. Peter Galle, Germany Surgical oncologist: Dr Michael Choti...

touchEXPERT OPINIONS for touchOPHTHALMOLOGY Listen to expert insights on how novel IOLs can address patients’ visual needs, the factors that influence IOL selection and managing patient expectations. The expert Dr Rosa Braga-Mele - Professor of Ophthalmology, Faculty of Medicine at the University of Toronto, Canada. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted ind...

touchPANEL DISCUSSION for touchONCOLOGY Listen as leading experts discuss the latest clinical data for emerging HER2-directed therapies and review novel therapeutic strategies and consider the implications for clinical practice. The experts Dr Laura Biganzoli – Department of Oncology, Hospital of Prato, Prato, Italy Dr Peter Fasching – Comprehensive Cancer Center, Erlangen-EMN, Friedrich-Alexander...

touchMDT for touchONCOLOGY Listen to a medical oncologist, a pathologist, a radiation oncologist and an oncology nurse practitioner discuss how to optimize treatment decisions, taking into account emerging therapies as well as patient expectations and preferences. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA  Pathologist: Prof. Keith Kerr, UK Radiation oncologist: Prof....

touchMDT for touchONCOLOGY Listen to a medical oncologist and a pathologist discuss the evolving role of biomarker testing in NSCLC in the light of emerging testing methodologies and treatment targets. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA  Pathologist: Prof. Keith Kerr, UK This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent...

Listen to a medical oncologist, a pathologist and an oncology nurse practitioner discuss the evolving treatment landscape and how treatment decisions need to take into account potential side effects. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA  Pathologist: Prof. Keith Kerr, UK Oncology nurse practitioner: Dr Marianne Davies, USA This touchPODCAST is for HCPs only. This...

touchMDT for touchONCOLOGY Listen to a medical oncologist and a radiation oncologist discuss the importance of the initial assessment in NSCLC and the role of the different members of the multidisciplinary team. The multidisciplinary team Medical oncologist: Dr Alexander Drilon, USA Radiation oncologist: Prof. Andrea Bejzak, Canada This touchPODCAST is for HCPs only. This activity is funded by an...

touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts review the latest advances in HR+ breast cancer, focusing on the management of specific patient subgroups and the potential impact of emerging oral, second-generation SERDs on patient standard of care. The experts Prof. Hope S Rugo – UCSF Comprehensive Cancer Center, San Francisco, CA, USA Dr Fatima Cardoso – Champalimaud Clinical C...

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of experts discuss the latest clinical research in HER2 dysregulation and potential HER2-targeted therapies in NSCLC. The experts Prof. Egbert Smit – Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands Dr Jarushka Naidoo – Beaumont Hospital, Dublin, Ireland Dr Katerina Politi – Yale School of Medicine, New...

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to leading experts discuss why the treatment landscape for patients with T2D and CKD requires novel therapies; why non-steroidal MRAs are being investigated in these patients and the latest clinical data; and how non-steroidal MRAs might fit into the current T2D and CKD treatment paradigm. The experts Prof. Christoph Wanner, University Hospital o...

touchPANEL DISCUSSION for touchONCOLOGY Listen to leading experts discuss evolving treatment options for patients with EGFR-mutant NSCLC, and the rationale for biomarker testing in both early-stage and metastatic disease to determine best treatment approaches, taking in recently presented data from the World Lung Cancer Congress and ESMO Congress 2021. The experts Dr Pasi Jӓnne, Dana-Farber Cancer...

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the mechanism linking obesity with T2D and share their observations from the clinic on the course of disease from obesity to T2D. The multidisciplinary team Primary care specialist: Professor Stewart Harris, Canada Endocrinologist: Professor Dr med Michael Nauck, Germany This touchPODCAST is for HCPs only....

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the importance of weight loss in T2D; GLP-1 RAs and SGLT2is and their association with weight loss; plus the patient’s experience of using a GLP-1 RA to manage their T2D and obesity.  The multidisciplinary team and patient Endocrinologist: Professor Dr med Michael Nauck, Germany Primary care s...

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient discuss real-world use of antihyperglycemic therapies to achieve an effective combination of glycemic control, weight loss and cardiovascular benefits.  The multidisciplinary team and patient Diabetes nurse practitioner: Dr Shannon Idzik, USA Primary care specialist: Professor Stewart Harris, Canada P...

touchCONGRESS for touchRESPIRATORY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for advanced NSCLC, including expert insights and interpretation from Dr Raffaele Califano (UK) and Prof. Anne-Marie Dingemans (The Netherlands). OVERVIEW Data review with Prof. Garon (0:00) Expert interview with Dr Califano, Prof. Dingemans and...

touchCONGRESS for touchONCOLOGY Listen to Prof. Edward Garon (USA) cover key data presented at ASCO and ESMO 2021 on optimizing frontline immunotherapy for advanced NSCLC, including expert insights and interpretation from Dr Raffaele Califano (UK) and Prof. Anne-Marie Dingemans (The Netherlands). OVERVIEW Data review with Prof. Garon (0:00) Expert interview with Dr Califano, Prof. Dingemans and Pr...

touchIN CONVERSATION for touchENDOCRINOLOGY Listen to Dr Vincent Woo in conversation with Dr Joanna Van. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for achieving individualized glycemic targets in patients with type 2 diabetes. This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational g...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team discuss how patients with endometrial cancer should be tested to determine suitability for PD-1/PD-L1 inhibitor therapy. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Pathologist: Dr Alicia León-Castillo This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independen...

touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team review a patient profile and describe how they would determine suitability for PD-1/PD-L1 inhibitor therapy. The multidisciplinary team Gynaecological oncologist: Prof. Nicole Concin Medical oncologist: Dr Antonio González-Martín Pathologist: Dr Alicia León-Castillo This touchPODCAST is for HCPs only. This activity is f...